- 全部删除
您的购物车当前为空
SB-435495 是一种具有口服活性、选择性和高效性的 Lp-PLA2 抑制剂(IC50值为0.06 nM),可用于研究自身免疫性葡萄膜炎和动脉粥样硬化。

SB-435495 是一种具有口服活性、选择性和高效性的 Lp-PLA2 抑制剂(IC50值为0.06 nM),可用于研究自身免疫性葡萄膜炎和动脉粥样硬化。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 497 | In stock | |
| 5 mg | ¥ 1,230 | In stock | |
| 10 mg | ¥ 1,980 | In stock | |
| 25 mg | ¥ 4,180 | In stock | |
| 50 mg | ¥ 5,930 | In stock | |
| 100 mg | ¥ 7,830 | In stock | |
| 200 mg | ¥ 10,800 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,890 | In stock |
SB-435495 相关产品
| 产品描述 | SB-435495 is an orally active, selective and potent Lp-PLA2 inhibitor (IC50 of 0.06 nM) for the study of autoimmune uveitis and atherosclerosis. |
| 靶点活性 | Lp-PLA2:0.06 nM |
| 体外活性 | SB-435495(5μM)在oxLDL暴露的HUVECs细胞中显著抑制了Lp-PLA2蛋白的表达。[3] |
| 体内活性 | SB-435495(30mg / kg,静脉注射,每天两次)可以显着降低Lp-PLA2在小鼠血浆中的活性。[2] |
| 别名 | SB435495, SB 435495 |
| 分子量 | 720.82 |
| 分子式 | C38H40F4N6O2S |
| CAS No. | 304694-39-1 |
| Smiles | O=C1N=C(SCC2=CC=C(F)C=C2)N(C=C1CC=3C=NN(C3)C)CC(=O)N(CC4=CC=C(C=C4)C=5C=CC(=CC5)C(F)(F)F)CCN(CC)CC |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (110.98 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容